November 16 | November 17 | November 18 | List (PDF) |
Monday, November 15 |
| 9:15— |
REGISTRATION OPENS, POSTER MOUNTING |
| 10:00— |
10th Annual Meeting of the Japan Endotoxin Society: |
|
|
15:30—16:15 |
Special Lecture |
|
|
Hiroyuki HIRASAWA |
|
|
Clinical Aspect of Hypercytokinemia in Critical Care
—Pathophysiology, Evaluation and Countermeasure— |
|
16:15—17:05 |
Invited Lecture I |
|
|
Ernst RIETSCHEL |
|
|
Chemical constitution and biological activities
of bacteria lipopolysaccharides |
|
17:05—17:55 |
Invited Lecture II |
|
|
Jack LEVIN |
|
|
The clinical significance of endotoxemia |
|
|
18:00— |
WELCOME PARTY |
November
16 | November 17 | November 18 | List
(PDF) |
Tuesday, November 16 |
|
8:00—08:30 |
Continental Breakfast, POSTER VIEWING |
|
8:20- |
OPENING CEREMONY Takashi Yokochi, Toshikazu Yoshikawa |
SESSION A — CHEMISTRY AND BIOLOGY OF ENDOTOXIN I |
|
Moderators:
Shoichi Kusumoto, Ulrich Zähringer |
1 |
08:30—08:55 |
Christopher WHITFIELD —Overview |
|
Evolutionary biology of endotoxin: from genomics to physiology |
2 |
08:55—09:20 |
Douglas GOLENBOCK — Overview |
|
Endotoxin signaling |
3 |
09:20—09:40 |
M. Stephen TRENT |
|
Remodeling of Helicobacter pylori LPS |
4 |
09:40—10:00 |
Russell BISHOP |
|
Structure and function of PagP |
|
10:00—10:20 |
Break |
5 |
10:20—10:40 |
Kiyoshi KAWASAKI |
|
Lipid A deacylation by PagL: regulation of TLR4 signaling |
6 |
10:40—11:00 |
Robert ERNST |
|
Biological relevance of lipid A variation in Yersinia species |
7 |
11:00—11:15 |
Thomas GUTSMANN |
|
Lipid-mediated resistance of Gram-negative bacteria against pore-forming anti-microbial peptides |
8 |
11:15—11:30 |
Rosevelt PARDY |
|
Molecules from eukaryotic algae possess LPS-like features but inhibit innate responses of mouse macrophages |
47 |
11:30—11:40 |
Selected ABSTRACT — Yukari FUJIMOTO |
|
Synthesis of lipid A and its novel analogues for investigation of the structural and conformational bases for their bioactivity |
63 |
11:40—11:50 |
Selected ABSTRACT — Anthony MORAN |
|
Helicobacter varies LPS antigenic structure to evade surfactant protein D |
|
12:00—13:00 |
LUNCH
BREAK |
|
12:00—13:00 (and beyond) |
LUNCH WORKSHOPS |
|
Room 104A
Molecular, structural and physical bases of cell activation by endotoxin |
12:00—12:10 |
Physicochemical characterization and endotoxic activity of
synthetic monophosphoryl analogues of lipid A |
|
Kent Myers, Klaus Brandenburg |
12:10—12:20 |
Physicochemical characterization and biologic activity of lipooligosaccharides
from Neisseria meningitidis |
|
Susu Zughaier |
12:20—12:30 |
A region of MD-2 required for the antagonistic activity of lipid IVA |
|
M Muroi |
12:30—12:40 |
Inhibition of cell activation: Shedding new light on antagonism |
|
Andra Schromm |
12:40 |
OPEN DISCUSSION |
Room 104B
Regulation of endotoxin-dependent and –independent TLR signaling |
12:00—12:10 |
Involvement of lipid rafts in lipopolysaccharide-induced
downregulation of surface TLR4 expression in TLR4/MD-2/CD14-CHO cells |
|
Tsuyoshi Shuto |
12:10—12:20 |
The tetraspanins CD37 and CD81 are involved in LPS signaling |
|
Holger Heine |
12:20—12:30 |
P. gingivalis and E. coli LPS differentially activate human gingival
fibroblasts and alter EGF and P2X7 nucleotide receptor expression |
|
Beatriz Quinchia-Rios |
12:30—12:40 |
IL-10 released by concomitant TLR2 stimulation blocks the induction
of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3
in human dendritic cells |
|
Fabio Re |
12:40 |
OPEN DISCUSSION |
|
|
13:00—14:30 |
POSTER VIEWING (47-147) |
SESSION B — CHEMISTRY AND BIOLOGY OF ENDOTOXIN II |
|
Moderators: Kenichi
Tanamoto, Ernst Rietschel |
9 |
14:40—15:00 |
Mareike MÜLLER |
|
Endotoxin: physical requirements for cell activation |
10 |
15:00—15:20 |
Kensuke MIYAKE |
|
Innate immune recognition of LPS by TLR4/MD-2 |
11 |
15:20—15:40 |
Theresa GIOANNINI |
|
Mechanisms of action of endotoxin agonists and antagonists |
12 |
15:40—16:00 |
Roman JERALA |
|
Structural interactions of LPS with MD-2 and neutralizing antagonists |
|
16:00—16:20 |
BREAK |
13 |
16:20—16:40 |
Nicholas GAY |
|
Structural determinants of Toll signaling: Spaetzle and MD-2 |
14 |
16:40—17:00 |
Kate FITZGERALD |
|
TRIF-related adaptor molecule (TRAM): a central player in LPS signaling |
35A |
17:00—17:20 |
Aisling DUNNE |
|
Mal: processing and post-translational modification |
89 |
17:20—17:30 |
Selected ABSTRACT — Jérôme PUGIN |
|
Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock |
96,97 |
17:30—17:40 |
Selected ABSTRACT — Susumu MATSUO |
|
Molecular and functional dissection of IκB-ζ, an endotoxin-induced transcriptional regulator |
100 |
17:40—17:50 |
Selected ABSTRACT — Mya Mya MU |
|
Inhibition of mitogen and stress-activated protein kinase 1/2 induces mitochondria-mediated apoptotic cell death in lipopolysaccharide-stimulated RAW 264.7 macrophage cells |
November
16 | November 17 | November 18 | List
(PDF) |
Wednesday, November 17 |
|
08:00—08:30 |
CONTINENTAL BEAKFAST,
POSTER VIEWING |
SESSION C — NEGATIVE REGULATION OF ENDOTOXIN ACTIVITY |
|
Moderators: Takashi Yokochi, Ulrich Seydel |
16 |
08:30—08:55 |
Robert MUNFORD — Overview |
|
Detoxifying endotoxin: time, place and person |
17 |
08:55—09:15 |
Patrick RENSEN |
|
Apolipoproteins modulate inflammatory responses to LPS in rodents and humans: implications for sepsis |
18 |
09:15—09:35 |
Richard KITCHENS |
|
Endogenous apolipoprotein E (apoE) and ATP-binding cassette transporter A1 (ABCA1) promote LPS efflux from macrophages |
19 |
09:35—09:55 |
Richard CHABY |
|
Interactions between LPS and surfactant proteins |
|
09:55—10:15 |
BREAK |
20 |
10:15—10:35 |
Mathias HORNEF |
|
Toll-like receptor-mediated recognition by intestinal epithelial cells |
21 |
10:35—10:55 |
Christopher KARP |
|
Negative regulation of TLR4 signaling by RP105 |
22 |
10:55—11:15 |
Mingfang LU |
|
Taming the humoral immune response to Gram-negative bacteria |
122 |
11:15—11:25 |
Selected ABSTRACT — Katharina BRANDL |
|
A complex of soluble TLR4 and MD-2 blocks LPS activity in vitro |
159 |
11:25—11:35 |
Selected ABSTRACT — Hyun-Ku LEE |
|
Double-stranded RNA-mediated TLR3 activation is enhanced by CD14 |
23 |
11:35—11:55 |
Ralf SCHUMANN |
|
Non-LPS actions and targets of LBP (LPS binding protein) |
|
12:00—14:00 |
LUNCH BREAK |
|
12:10—13:10 |
LUNCHEON
SEMINAR |
|
|
Co-organized by
Seikagaku Corporation |
|
“New Developments
in (1,3)- beta-D-Glucan Research.”
Program [PDF, 20KB]
Abstracts [PDF,
40KB] |
SESSION D — CHEMISTRY AND BIOLOGY OF OTHER MICROBIAL TARGETS OF INNATE IMMUNITY |
|
Moderators: Yoshio Kumazawa, Artur Ulmer |
24 |
14:00—14:25 |
Kiyoshi TAKEDA — Overview |
|
Evolution and integration of innate immune recognition systems: the Toll-like receptors |
25 |
14:25—14:40 |
Roman DZIARSKI — Overview |
|
Peptidoglycan recognition and innate immunity |
26 |
14:40—15:00 |
Dominique MENGIN-LECREULX |
|
Bacterial cell wall peptidoglycan: structure, function and metabolism |
27 |
15:00—15:20 |
Roy MARIUZZA |
|
Crystal structure of PGRP domains (± ligand) |
|
15:20—15:40 |
BREAK |
28 |
15:40—16:00 |
Stephen GIRARDIN |
|
Nod1 and Nod2 are pattern-recognition molecules involved in peptidoglycan recognition |
29 |
16:00—16:20 |
Thomas HARTUNG |
|
Structural and molecular determinants of pro-inflammatory properties of lipoteichoic acids |
30 |
16:20—16:40 |
Kasper HOEBE |
|
CD36 as a sensor of diacylglycerides acting in conjunction with TLR2 and TLR6 |
31 |
16:40—17:00 |
Ken-Ichiro SHIBATA |
|
Structure—activity relationships of bacterial lipopeptides with TLR2/heterodimers |
|
17:00—18:30 |
BUSINESS MEETING
BANQUET |
November
16 | November 17 | November 18 | List
(PDF) |
Thursday, November 18 |
|
08:00—08:30 |
CONTINENTAL BEAKFAST,
POSTER VIEWING |
SESSION E — BASIC AND CLINICAL CONCEPTS IN INNATE IMMUNITY I |
|
Moderators: Haruhiko Takada, Alan Cross |
32 |
08:30—08:55 |
Jean-Marc REICHHART — Overview |
|
Evolution and integration of innate immune systems from fruit flies to man: lessons and questions |
33 |
08:55—09:15 |
Neal SILVERMAN |
|
Monomeric and polymeric Gram-negative peptidoglycan, but not purified LPS, activate Drosophila IMD pathway |
34 |
09:15—09:35 |
Teizo FUJITA |
|
Pattern recognition and lectin-complement pathway |
|
09:35—09:45 |
Selected ABSTRACT — Sandra S.H. TAN |
|
Recombinant C-reactive protein from the horseshoe crab is a
potent pathogen recognition receptor (PRR) |
|
09:45—10:05 |
BREAK |
36 |
10:05—10:25 |
Akihiko YOSHIMURA |
|
SOCS1 and SOCS3 are central regulators for macrophage and dendritic
cell activation |
37 |
10:25—10:45 |
Jean-Marc CAVAILLON |
|
Reprogramming of circulatory cells in sepsis and SIRS |
38 |
10:45—11:05 |
Tsukasa SEYA |
|
TLRs and their adaptors in adjuvant immunotherapy for cancer |
15 |
11:05—11:25 |
Kenya HONDA |
|
Identification of a cytosolic complex involving
MyD88 and the transcription factor IRF-7 that triggers Toll-like receptor-induced
IFN-α/β gene expression |
188 |
11:25—11:35 |
Selected ABSTRACT — Minou ADIB-CONQUY |
|
Cross-talk between Nod1, Nod2 and Toll-like receptors (TLRs) for cytokine production by macrophages in response to Gram-positive bacteria |
208 |
11:35—11:45 |
Selected ABSTRACT — Ofer LEVY |
|
Human newborn blood monocytes demonstrate low TNF-α but high IL-6 responses to an array of Toll-like receptor ligands: role of a low-molecular weight plasma inhibitor of TNF-α release |
196 |
11:45—11:55 |
Selected ABSTRACT — Basel AL-RAMADI |
|
CD154 is essential for protection against Gram-negative Salmonella infections |
184 |
11:55—12:05 |
Selected ABSTRACT — Dawn BOWISH |
|
The host defence peptide LL-37 is a multi-functional immunomodulator which interacts directly with the effector cells of the innate immune response |
|
12:05—13:00 |
LUNCH
BREAK |
|
12:15—13:15 (and beyond) |
LUNCH WORKSHOPS |
|
Room 104A
Host responses to infection: Innate immune mechanisms |
12:15—12:25 |
The acute phase protein haptoglobin prevents
hemoglobin-induced dispersion of LPS aggregates and suppresses the hemoglobin-mediated
enhancement of cellular activation by LPS |
|
Christian Alexander |
12:25—12:35 |
CD14 and TLR2 Pattern Recognition Receptors differentially modulate host
response to S. pneumoniae in vivo and in vitro |
|
Regina Landmann |
12:35—12:45 |
Pattern recognition receptor deficiency compromises host resistance
to pneumonic Tularemia |
|
Tim Sellati |
12:45—12:55 |
A non-tolerizing dose of Gram-negative bacterial lipopolysaccharide
primes anti-bacterial host defenses: a model for the role of endotoxin
in innate immunity |
|
Alan Cross |
12:55 |
OPEN DISCUSSION |
Room 104B
Structural bases of interactions between acylated bacterial compounds (endotoxin
and beyond) and host peptides/proteins |
12:15—12:25 |
Structure/function studies on endotoxin-neutralizing
and antibacterial peptides derived from NK-lysin |
|
Jörg
Andrä |
12:25—12:35 |
Biophysical characterization of the interaction of Limulus polyphemus
endotoxin-neutralizing protein (ENP) with LPS |
|
Klaus Brandenburg |
12:35—12:45 |
MARCKS-LPS interaction in epithelial cells and its effect on actin filament
depolymerization |
|
Roman Jerala |
12:45—12:55 |
Structure-activity relationship of signaling by synthetic lipopeptides
through TLR2/TLR6 and TLR2/TLR1 heterodimers |
|
Artur Ulmer |
12:55 |
OPEN DISCUSSION |
|
|
13:00—14:30 |
POSTER VIEWING (148-232) |
SESSION F — BASIC AND CLINICAL CONCEPTS IN INNATE IMMUNITY II |
|
Moderators:
Hiroshi Fukui, , Jérôme Pugin |
39 |
14:35—15:00 |
Stefanie VOGEL — Overview |
|
Genetic bases of host responses to endotoxin and resistance to infection |
40 |
15:00—15:20 |
Moshe ARDITI |
|
TLRs and Atherosclerosis |
41 |
15:20—15:40 |
Mathias CHAMAILLARD |
|
Nod2: from human genetics to pathophysiology of Crohn's disease |
42 |
15:40—16:00 |
Hans FISCHER |
|
Toll-like receptor 4 discriminates pathogens from commensals through pathogen specific recognition receptors |
|
16:00—16:20 |
BREAK |
43 |
16:20—16:40 |
Anne PUEL |
|
Inherited human IRAK-4 deficiency and infectious diseases |
44 |
16:40—17:00 |
David PERSING |
|
Short- and long-term suppression of atopic responses in the airways by TLR-4 agonists |
45 |
17:00—17:20 |
Alfred AYALA |
|
The role and regulation of apoptosis in sepsis |
46 |
17:20—17:40 |
Kelly SMITH |
|
A systems approach to study of sepsis and innate immunity |
|
17:40 |
CLOSING REMARKS; ADJOURNMENT |